Skip to main navigation Skip to search Skip to main content

Exposure–response of veliparib to inform phase II trial design in refractory or relapsed patients with hematological malignancies

  • Shailly Mehrotra
  • , Mathangi Gopalakrishnan
  • , Jogarao Gobburu
  • , Jiuping Ji
  • , Jacqueline M. Greer
  • , Richard Piekarz
  • , Judith E. Karp
  • , Keith W. Pratz
  • , Michelle A. Rudek

Research output: Contribution to journal › Article › peer-review

4   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Exposure–response of veliparib to inform phase II trial design in refractory or relapsed patients with hematological malignancies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science